Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

795.72 +7.53 (+0.96%)
Streaming Delayed Price Updated: 12:59 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
Eli Lilly's Growth Prospects Just Got a Huge Upgrade
The company's promising Alzheimer's drug could soon obtain approval from regulators. 
Via The Motley Fool
Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions
Eli Lilly & Co has intensified its fight against counterfeit versions of its popular obesity drug, Zepbound, by initiating additional legal proceedings against companies selling compounded versions of... 
Via Benzinga
Eli Lilly's Stock Surge Driven by GLP-1 Demand
Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs 
Via MarketBeat
Topics Economy
Exposures Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Alzheimer's Drug Stocks: Investing in Eli Lilly, Biogen, Roche
The race to develop effective Alzheimer's treatments presents significant opportunities and inherent risks for healthcare investors. 
Via MarketBeat
Exposures Product Safety
(LLY) - Analyzing Eli Lilly and Co's Short Interest
Via Benzinga
Here's How Much $1000 Invested In Eli Lilly and Co 10 Years Ago Would Be Worth Today
Via Benzinga
Eli Lilly Stock Analysis: Buy, Hold, or Sell?
Eli Lilly is ramping up manufacturing to meet the soaring demand for its innovative medicines. 
Via The Motley Fool
Eli Lilly Hits All-Time High, Named To Big Cap 20 List: Check These Lists For Best Stocks To Buy
Eli Lilly stock has been on an astounding run. In 2009 its stock sold for 27.21 a share. It closed Tuesday at 891.46, up 3,149% from 2009. 
Via Investor's Business Daily
The Best Biotech Stock to Invest $1,000 in Right Now
This stock may not be a slam dunk, but it's looking very promising. 
Via The Motley Fool
3 Strong Buy Stocks for a Sizzling Summer Rally
Investors can take a deep breath before the next earnings season, but they should still invest in equities, including these three gems hiding in plain sight 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
The company tested a GLP-1 drug in monkeys. But it might not actually be an obesity treatment. 
Via Investor's Business Daily
Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Activity
Via Benzinga
Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
Via Benzinga
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for... 
Via Benzinga
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade. 
Via The Motley Fool
Will Walmart Reach a Trillion-Dollar Market Cap by 2030?
This seemingly unlikely non-tech name quietly deserves to be on the list of contenders that could achieve the feat in the foreseeable future. 
Via The Motley Fool
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
The company has too many weapons at its disposal. 
Via The Motley Fool
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
The drugmaker continues to make headlines for all the right reasons. 
Via The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Want peace of mind about your investments? Consider these great stocks. 
Via The Motley Fool
Exit Alert: 3 Stocks to Offload Before the Downturn
Discover why three top stocks to sell now are facing challenges in technology hardware, pharmaceuticals and automobile manufacturers. 
Via InvestorPlace
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
The company just unveiled preclinical results from a test of its GLP-1 weight-loss drug. 
Via Investor's Business Daily
Stock Market Hits Highs; Tame Inflation, Fed Meeting, Apple, Broadcom, Oracle, Tesla: Weekly Review
The Dow Jones fell amid weak-to-lackluster market breadth. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
7 A-Rated Biotech Stocks Worth Betting on in June
A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation. 
Via InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
GLP-1s are a weight-loss breakthrough, but these three stocks to sell have a lot to lose from their rapid rise in popularity. 
Via InvestorPlace
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
Novo Nordisk's competition in the obesity drug market is heating up. 
Via The Motley Fool
Weight Loss Drugs: Are They Really Magic?
Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs." 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
JPMorgan's $500M Venture Capital Fund Bets Big On Weight-Loss Drugs: 'They're All The Rage'
JPMorgan's $500M venture capital fund dives into weight-loss craze, eyeing potential market upheaval in pharmaceuticals. 
Via Benzinga
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
One of the best ways to spot winning stocks to buy is by spotting hot trends, such as artificial intelligence and obesity. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.